Effectiveness of a Psychological Intervention on Mental Health and Sleep.
Insomnia Chronic, Anxiety, Depression
About this trial
This is an interventional treatment trial for Insomnia Chronic focused on measuring INSOMNIA, ANXIETY, LIFE QUALITY, teleconsultation, LONG COVID
Eligibility Criteria
Inclusion Criteria: Have a personal pathological history of diagnosis of COVID-19 (mild or severe) by PCR test or antigen test in the last 6 months. Present symptoms of insomnia. Present anxiety symptoms. Present symptoms of depression. Be between 18 and 40 years old. Have digital devices such as a computer, tablet or smartphone with internet access. Exclusion Criteria: Being in psychological or pharmacological treatment to control insomnia, anxiety, depression, at the time of the study. Presenting symptoms of another sleep disorder such as obstructive sleep apnea, restless legs syndrome, or sleep disorder due to work hours (1). Suffering from cardiorespiratory or neurological sequelae of COVID-19 do not allow the participant to take the treatment. Consume psychoactive substances of abuse (Cannabis, cocaine, solvents, cannabidiol).
Sites / Locations
- Horacio Balam Álvarez García
Arms of the Study
Arm 1
Other
Brief Behavioral Intervention in Insomnia through Tele-Consultation (BBII-TC)
Brief therapy organized into four sessions, lasting 60 minutes each, where behavioral therapy techniques are taught (stimulus control, sleep restriction, progressive muscle relaxation, sleep hygiene). The teleconsultation modality is given through the ZOOM platform synchronously.